Skip to main content

Animations

MJFF Publications

5341 - 5350 of 6403 Results
Title
Year
  • Year
  • 2020
  • 2025
  • 2017
  • 2014
  • 2023
  • 2023
  • 2021
  • 2019
  • 2022
  • 2021
  • Summary Details
    OPEN
    Title: Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.aba1193
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Conducting Polymer Microelectrode Arrays for Simultaneous Electrophysiology and Advanced Brain Imaging
    Journal Name: Advanced Functional Materials
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/adfm.202417312
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Particle swarm optimization for programming deep brain stimulation arrays
    Journal Name: Journal of Neural Engineering
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1088/1741-2552/aa52d1
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2014.04.027
    Citation Count: 130
  • Summary Details
    OPEN
    Title: Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-023-02585-x
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13506
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Closed-Loop Deep Brain Stimulation to Treat Medication-Refractory Freezing of Gait in Parkinson’s Disease
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2021.633655
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2019.04.033
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2121609119
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the Brain
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acschemneuro.1c00641
    Citation Count: 26
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.